Fingerprint
Dive into the research topics of 'The development of imatinib as a therapeutic agent for chronic myeloid leukemia'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
The development of imatinib as a therapeutic agent for chronic myeloid leukemia
Michael Deininger, Elisabeth Buchdunger, Brian J. Druker
Research output: Contribution to journal › Review article › peer-review
1089
Scopus
citations